Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS). https://mma.prnewswire.com/media/1219482/Glancy_Prongay_and_Murray_LLP.jpg IF YOU SUFFERED A LOSS ON YOUR HIMS INVESTMENTS, CLICKHEREBEFORE AUGUST 25, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD […]

KLC Investor Update: Class Action Lawsuit Filed Against KinderCare Over IPO- Hagens Berman

(NYSE:KLC), SAN FRANCISCO, Aug. 21, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit has been filed on behalf of investors who purchased shares in KinderCare (NYSE: KLC) during its October 2024 initial public offering (IPO). The lawsuit alleges that the company made false and misleading statements in its IPO documents, failing to disclose significant

KLC Investor Update: Class Action Lawsuit Filed Against KinderCare Over IPO- Hagens Berman

KLC Investor Update: Class Action Lawsuit Filed Against KinderCare Over IPO- Hagens Berman GlobeNewswire August 21, 2025 SAN FRANCISCO, Aug. 21, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit has been filed on behalf of investors who purchased shares in KinderCare (NYSE: KLC) during its October 2024 initial public offering (IPO). The lawsuit alleges

Andalos brand pastry products recalled due to Salmonella

Product: Pastry products Issue: Food – Microbial contamination – Salmonella Distribution: Online New Brunswick Nova Scotia Ontario Quebec See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA) https://rt.newswire.ca/rt.gif?NewsItemId=C3100&Transmission_Id=202508211631CANADANWWEB______C3100&DateId=20250821

Bragar Eagel & Squire, P.C. Reminds Investors of KinderCare, CTO Realty, and Charter Communications that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm

(NYSE:KLC),(NYSE:CTO),(NASDAQ:CHTR), NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of KinderCare Learning Companies, Inc. (NYSE:KLC), CTO Realty Growth, Inc. (NYSE:CTO), and Charter Communications, Inc. (NASDAQ:CHTR). Stockholders have until the deadlines below

Bragar Eagel & Squire, P.C. Reminds Investors of KinderCare, CTO Realty, and Charter Communications that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Reminds Investors of KinderCare, CTO Realty, and Charter Communications that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm GlobeNewswire August 21, 2025 NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions

Honeywell Announces Filing of Form 10 Registration Statement and Upcoming Investor Day for Planned Spin-Off of Solstice Advanced Materials

— Solstice Advanced Materials will be a pure-play specialty materials company with leading market positions in refrigerants, semiconductor materials, protective fibers, and healthcare packaging solutions — Filing marks latest milestone as Solstice prepares to become a standalone public company in the fourth quarter of 2025 — Investor Day scheduled for October 8, 2025, in New

Honeywell Unveils Strategic Board of Directors to Lead Solstice Advanced Materials

— Board Comprises Senior Leaders with Innovation, Technology, and Industrial Sector Expertise — Spin-Off On Track for Completion in the Fourth Quarter of 2025 Honeywell (NASDAQ: HON) today announced the future Board of Directors for Solstice Advanced Materials (“Solstice”), a pure-play specialty materials company that will be created following its planned spin-off from Honeywell. Solstice

QuidelOrtho Completes Debt Refinancing

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced the completion of a series of related transactions to refinance its debt structure and support future growth. Through these transactions, the Company extended its debt maturities and reduced

INVESTOR DEADLINE AUGUST 25: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – SRPT

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025, inclusive (the “Class Period”), have until Monday, August 25, 2025 to seek appointment as lead plaintiff of the Sarepta class action lawsuit. CaptionedDolgicer v. Sarepta

Scroll to Top